MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
Olfactory dysfunction predicting cognition

X. Yu (Cleveland, OH, USA)

Cognitive Disorders  ·  Hall 3FG
1:45pm-3:15pm
Oligosymptomatic Fahr’s syndrome (2 clinical cases)

Y. Solodovnikova (Odessa, Ukraine)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG
1:45pm-3:15pm
On Converting Patients From Oral Dopamine Agonists to the Carbidopa/Levodopa Enteral Suspension Method – Real World Conversion Ratios

S. Nakano, L. Bahroo, F. Pagan, F. Amjad, S. Lo, I. Gambhir (Washington, D.C., DC, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Ondansetron, a highly-selective 5-HT3 receptor antagonist, alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

C. Kwan, I. Frouni, D. Bédard, A. Hamadjida, P. Huot (Montreal, QC, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Open-label extension (OLE) of a multiple ascending dose (MAD) study of BIIB092 in participants with PSP: Safety analysis

T. Dam, L. Zhang, I. Qureshi, M. Grundman, G. Tirucherai, C. Bechtold, M. Ahlijanian, L. Golbe, L. Honig, S. Isaacson, M. Grossman, N. McFarland, I. Litvan, D. Geldmacher, T. Xie, Y. Bordelon, P. Tuite, P. O’Suilleabhain, T. Zesiewicz, B. Han, A. Boxer (Cambridge, MA, USA)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Optimized Imaging at 3.0 T of the Rostral Zona Incerta (rZI) for Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)

A. Thaker, K. Reddy, J. Thompson, P. David-Gerecht, A. Abosch, D. Kern (Aurora, CO, USA)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Optimizing the Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) outcome in Parkinson’s disease patient with interleaving stimulation

C. Lau, C. Zhu, D. Chan, K. Ma, A. Chan, J. Yeung, V. Mok, W. Poon (Hong Kong)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Oral treatment with JNX3001 protects dopaminergic function in a non-human primate model of Parkinson’s disease alpha-synucleinopathy

P. Howson, T. Johnston, J. Brotchie, M. Hill, J. Koprich (Toronto, ON, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Oral treatment with sphingosine-1-phosphate receptors modulator prevents Parkinson symptoms concomitantly to reduced brain inflammation in MPTP mouse models

M. Cyr, E. Pépin, G. Massicotte (Trois-Rivieres, QC, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Outcomes of a Prospective, Multi-center International Registry of Deep Brain Stimulation for Parkinson’s Disease

G. Deuschl, R. Jain, H. Scholtes, A. Wang, M. Barbe, S. Paschen, A. Andrea Kühn, M. Pötter-Nerger, J. Volkmann, J. Vesper (Kiel, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 59
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley